当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Tabár L, Dean PB, Chen SL, Chen HH, Yen AM, Fann JC, Chiu SY, Smith RA and Duffy SW
We compared the survival of women diagnosed with invasive lobular carcinoma subtypes prior to and during the mammography screening era to determine the impact of early detection and treatment in an early phase upon survival according to tumor subtypes. Using mammographic tumor features, we classified 428 consecutive invasive lobular carcinoma cases of the breast into four subgroups according to their mammographic tumor features.
Life-table-based survival curves and adjusted survival curves with the accelerated failure time method were plotted to demonstrate the 14-year follow-up survival outcome with adjustment for tumor size, node status, histologic malignancy grade, tumor focality and treatment. Survival of invasive lobular carcinoma subtypes was substantially improved as a result of early detection through mammography screening and treatment in an early phase, except for the subtype presenting as architectural distortion on the mammogram, even with the use of modern therapeutic methods. There is a clear need to further develop diagnostic and management strategies to decrease mortality from the diffusely infiltrating special subtype of invasive lobular carcinoma.